Theranostics Market Size Worth USD 8.67 billion by 2034 | CAGR: 15.5%
The theranostics market size is expected to reach USD 8.67 Billion by 2034, according to a new study by Polaris Market Research. The report “Theranostics Market Size, Share, Trends, Industry Analysis Report: By Product Type (Instruments, Reagents, and Software), Application, Technology, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Theranostics is a medical approach that integrates diagnostics and therapy to provide personalized treatment based on a patient’s specific disease characteristics. This method enables precise disease detection, targeted therapy, and real-time monitoring of treatment effectiveness. The theranostics market growth is propelled by the increasing prevalence of cancer and other chronic diseases, advancements in molecular imaging, and the rising adoption of precision medicine.
Theranostics market opportunities lie in the expansion of radiotheranostics, AI-driven diagnostic solutions, and biomarker-based therapies. Key trends include the growing use of companion diagnostics, regulatory support for personalized treatments, and strategic collaborations among pharmaceutical, biotechnology, and diagnostic companies. With continuous innovation and increasing demand for targeted therapies, the market is expected to expand further, particularly in oncology and neurology applications.
Theranostics Market Report Highlights
- North America held the largest revenue share of 46.2% in 2025. The dominance is fueled by the strong presence of advanced healthcare infrastructure and high adoption of precision medicine.
- The Asia Pacific theranostics market is expected to register the highest CAGR of 17.0% during the forecast period. The rapid development of healthcare infrastructure and rising prevalence of chronic diseases boost the growth.
- The reagents segment dominated with 47.9% share in 2025. This is attributed to the critical role they play in diagnostic tests, including biomarker assays and molecular diagnostic applications.
- The oncology segment led the market with 62.7% share in 2025. It is propelled by the rising prevalence of cancer globally and the increasing adoption of targeted therapies for the disease treatment.
- The hospital segment held the largest share of 48.3% in 2025. Hospitals play a key role in patient care. They can integrate advanced diagnostic and therapeutic technologies.
- The theranostics market comprises several active companies contributing to advancements in personalized medicine. A few notable participants include Advanced Accelerator Applications; Bayer AG; GE HealthCare Technologies Inc.; Siemens Healthineers AG; Cardinal Health, Inc.; Lantheus Holdings, Inc.; Curium Pharma; Abbott Laboratories; Thermo Fisher Scientific Inc.; Astellas Pharma Inc.; F. Hoffmann-La Roche AG; and Illumina, Inc.
Request a free sample copy or read the full market insights: Theranostics Market
Polaris Market Research has segmented the theranostics market report on the basis of product type, application, technology, end user, and region:
By Product Type Outlook (Revenue – USD Billion, 2021–2034)
- Instruments
- Reagents
- Software
By Application Outlook (Revenue – USD Billion, 2021–2034)
- Oncology
- Neurology
- Cardiology
- Infectious Diseases
By Technology Outlook (Revenue – USD Billion, 2021–2034)
- Genomics
- Proteomics
- Metabolomics
- Biomarkers
By End User Outlook (Revenue – USD Billion, 2021–2034)
- Hospitals
- Diagnostic Laboratories
- Research Institutes
By Regional Outlook (Revenue – USD Billion, 2021–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Theranostics Market Report Scope
| Report Attributes | Details |
| Market Size Value in 2025 | USD 2.36 Billion |
| Market Size Value in 2026 | USD 2.72 Billion |
| Revenue Forecast by 2034 | USD 8.67 Billion |
| CAGR | 15.5% from 2026 to 2034 |
| Base Year | 2025 |
| Historical Data | 2021–2024 |
| Forecast Period | 2026–2034 |
| Quantitative Units | Revenue in USD Billion and CAGR from 2026 to 2034 |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regional Scope |
|
| Competitive Landscape |
|
| Report Format |
|
| Customization | Report customization as per your requirements with respect to countries, regions, and segmentation. |
Source: Polaris Market Research Analysis
